2023 Research Grant Program recipients announced, read more here.
One of Macular Disease Foundation Australia’s key objectives is to support research, with the aim of reducing the incidence and impact of macular disease. And so, in 2011, MDFA launched its Research Grants Program.
Over the life of the Research Grants Program, MDFA has become the largest non-government source of research funds for macular disease in Australia.
Key statistics of the Research Grants Program
Total funds committed since 2011 | $5.9 million |
Number of projects funded since 2011 | 34 projects |
Of course, the ultimate aim of research is to make sight-saving discoveries for all macular conditions. However, many MDFA-funded projects are directed to foundational research, which is crucial to our understanding of macular disease.
Only Australian researchers, working at an Australian institution, are eligible for MDFA’s Research Grants Program funding.
2023 Research Grants Program
In 2023, MDFA awarded three research grants worth a total of $560,000. An additional $150,000 will fund three early-career researchers undertaking innovative “blue sky” research into macular disease as part of the Grant Family Fund, which is possible as a result of a generous bequest made in memory of the late Faye Grant.
-
Dr Carla Abbott
Dr Carla Abbott is from Centre for Eye Research Australia, University of Melbourne.
Project title: Composition and functionality of high-density lipoprotein in age-related macular degeneration and a high-risk disease phenotype
-
Prof Chandrakumar Balaratnasingam
Chandra Balaratnasingam is from Lions Eye Institute, University of Western Australia.
Project title: Spatial transcriptomics in diabetic macular ischaemia
-
Prof Gerald Liew
Professor Gerald Liew is from Westmead Institute for Medical Research, University of Sydney.
Project title: Investigating Mitochondrial Dysfunction in Macular Degeneration – Towards New Treatments and Biomarkers =
-
Dr Alexis Ceecee Britten-Jones
Dr Alexis Ceecee Britten-Jones is from University of Melbourne.
Project title: Redefining macular disease diagnosis to improve access to emerging therapies
-
Dr Xavier Hadoux
Dr Xavier Hadoux is from Centre for Eye Research Australia, University of Melbourne.
Project title: Evaluating the potential of hyperspectral imaging for detecting and monitoring geographic atrophy
2021 Research Grants Program
In 2021, MDFA allocated more than $1 million through two distinct funding streams.
Under the MDFA Research Grants Program, a total pool of just under $935,000 was allocated to six research projects.
In addition, a total pool of just over $90,000 was allocated to two early-career researchers as part of the new Grant Family Fund.
-
A/Prof Anai Gonzalez-Cordero
A/Prof Anai Gonzalez-Cordero is from Children’s Medical Research Institute, the University of Sydney.
Project title: Creating a macula in retinal organoids
This project aims to create an ‘organoid’, which is essentially a mini eye in a dish, that can used as a laboratory model for macular degeneration. This will address the lack of available animal models that replicate the macula which has hindered the study and development of new therapies.
-
Dr Ting Zhang
Dr Ting Zhang is from Save Sight Institute, the University of Sydney.
Project title: Activating endogenous phosphoglycerate dehydrogenase (PHGDH) to treat age-related macular degeneration with the help of a Müller cell-specific lipid nanocarrier
This project will use gene manipulation to activate an enzyme called PHGDH which will then be delivered to Müller cells in the retina. PHGDH plays an important role in Müller cells by reducing oxidative and mitochondrial stress. The results of this research may lead to the discovery of new AMD treatments.
-
Associate Professor Chi Luu
A/Prof Chi Luu is from the Centre for Eye Research Australia.
Project title: Relationships between choriocapillaris endothelial function, photo receptor health and AMD phenotypes.
This project will use an innovative imaging technique to improve our understanding of the causes of age-related macular degeneration (AMD) and help develop new treatment strategies.
-
Professor Justine Smith
Prof Justine Smith is from Flinders University.
Project title: Targeting inflammatory cytokines in macular oedema.
This project will use human eye cells to create disease models in the laboratory. It will then use these to explore the possibility of treating macular oedema by blocking the actions of molecules called ‘cytokines’. Macular oedema is responsible for sight loss in diverse macular conditions – from diabetic eye disease to retinitis pigmentosa.
-
Associate Professor Matthew Simunovic
A/Prof Matthew Simunovic is from the Save Sight Institute, University of Sydney.
Project title: Optogenetic restoration of vision in macular degeneration with high-sensitivity Type I and Type II opsins.
This project aims to eventually restore sight lost to macular degeneration using a type of gene therapy called ‘optogenetics’. Optogenetic gene therapy makes the ordinarily light-insensitive nerve cells that survive in advanced macular degeneration sensitive to light: it can therefore be considered a biological equivalent of the bionic retina.
-
Ms Diana Tang
Ms Tang is from Macquarie University.
Project title: The development, implementation and evaluation of an online Movement, Interaction and Nutrition for Greater Lifestyles in the Elderly (MINGLE) program for people with age-related macular degeneration.
This study aims to improve the mental and physical health of people living with age-related macular degeneration through the MINGLE program. The program is led by an accredited practicing dietician and a physical activity researcher.
-
Dr Sheela Kumaran
Dr Kumaran is from the University of New South Wales.
Project title: Measuring the breadth and the depth of the quality-of-life impacts caused by age-related macular degeneration.
This project aims to improve the way the impact of age-related macular degeneration (AMD) on quality of life is measured. This will help assess the effectiveness of various interventions. It will also help our understanding of the economic impacts of AMD.
-
Dr Yvette Wooff
Dr Wooff is from Australian National University.
Project title: Treat yourself! The use of therapeutically-loaded extracellular vesicles as a novel gene therapy for the treatment of age-related macular degeneration.
This project will investigate the possibility of restoring communication between cells by therapeutically supplementing the natural molecular message of retinal health as a therapy. It is hoped that doing so will help maintain retinal health and slow the progression of retinal degeneration.
2019 Research Grants Program
MDFA awarded a total pool of $600,000 to three leading researchers in a prestigious event held at Admiralty House, the Governor-General of Australia’s residence in Sydney, on World Sight Day (10 October).
The awards were announced by His Excellency the Honourable David Hurley, Governor-General of Australia. The investments were made in three very different but equally important projects.
-
Professor Alex Brown
Prof Brown is from the Aboriginal Health Equity Theme at the South Australian Health and Medical Research.
Project title: Defining the Risk and Epidemiology of Aboriginal Australian Macular Disease, hence its name: The DREAM project.
This research aims to advance understanding of the underlying social, psychological, environmental, behavioural, clinical, biological and metabolomic risk factors of diabetic retinopathy (DR) and diabetic macular oedema (DMO) among Aboriginal people.
-
Dr Audra Shadforth
Dr Shadforth is from the School of Environment and Science, Griffith University.
Project title: Investigating the potential for scar-less wound healing in age-related macular degeneration.
Late-stage AMD includes the eventual development of sub-retinal fibrosis, and nearly half of eyes treated with anti-VEGF injections will continue to develop blinding scars within two years of treatment.
This research will investigate the cells and mechanisms responsible for scar tissue formation under the macula, using emergent technologies and important clues from studies on human tissues capable of regenerative healing.
This study aims to inform the development of new, sustainable treatments for AMD patients.
-
Dr Zhichao Wu
Dr Wu is from the Centre for Eye Research Australia.
Project title: Novel prognostic imaging biomarkers for improved risk stratification in the early stages of age-related macular degeneration.
This research aims to investigate better methods for detecting and monitoring AMD using optical coherence tomography (OCT), an imaging technique, and artificial intelligence. The study will obtain imaging from 200 participants with intermediate age-related macular degeneration, which will inform clinical practice.
2017 Research Grants Program
His Excellency General the Honourable Sir Peter Cosgrove, Governor-General of Australia awarded three research grants totalling $600,000 to three of Australia’s leading researchers on behalf of Macular Disease Foundation Australia in November 2017.
-
Professor Alice Pébay
Institution: Department of Anatomy and Neurosciences, University of Melbourne
Project title: Modelling geographic atrophy using human pluripotent stem cells.
-
Professor Erica Fletcher
Institution: Department of Anatomy and Neuroscience, University of Melbourne
Project title: Targeting monocyte phagocytosis to reduce progression of age-related macular degeneration.
-
Dr Fred Chen
Institution: Centre for Ophthalmology and Visual Science, The University of Western Australia
Project title: Stargardt macular degeneration – finding new genetic mutation and preparing patients for clinical trial.
2016 Research Grants Program
Two projects received grants totalling $130,000 from MDFA in 2016.
-
Associate Professor Wilson Heriot
Institution: Department of Optometry and Vision Sciences, University of Melbourne
Project title: Plaquenil and chloroquine phototoxicity.
-
Professor Bamini Gopinath
Institution: Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney
Project title: ‘Caring for the Carer’: implementing a comprehensive support service model for family caregivers looking after persons with age-related macular degeneration.
Prof Gopinath’s study is supported by an Australian National Health and Medical Research Council Partnership Project Grant.
2015 Research Grants Program
The Governor-General Sir Peter Cosgrove awarded Macular Disease Foundation Australia’s 2015 grants to world-leading Australian researchers in October 2015.
MDFA Research Grants funded three projects worth $700,000 in total. In addition, there were two Blackmores Macular Disease Foundation Australia Research Grants – each worth $100,000 – for research specifically into dietary and lifestyle aspects of macular degeneration.
An additional $400,000 grant was awarded as a combined Macular Disease Foundation Australia Research Grant / Blackmores Macular Disease Foundation Australia Research Grant.
The 2015 grants totalled $1.3 million.
-
Professor Mark Gillies
Institution: Save Sight Institute, University of Sydney
Project title: How to get the best outcomes of treatment of neovascular age-related macular degeneration with vascular endothelial growth factor inhibitors: real world evidence.
-
Associate Professor Chi Luu
Institution: Centre for Eye Research Australia
Project title: Static and dynamic retinal function topography in early stages of age-related macular degeneration.
-
Associate Professor Gerald Liew
Institution: Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney
Project title: Deciphering the metabolomics signature of age-related macular degeneration to discover pathogenic pathways.
-
Associate Professor Isabelle Jalbert
Institution: School of Optometry and Vision Science, University of New South Wales
Project title: Eye care practitioners’ and patients’ perspectives on age-related macular degeneration; identifying barriers and facilitators to optimal age-related macular degeneration care.
-
Associate Professor Laura Downie
Institution: Department of Optometry and Vision Sciences, University of Melbourne
Project title: Advancing eye care for people with age-related macular degeneration (AMD) through integrating clinical research and its translation.
-
Professor Steven Krilis
Institution: Infectious Diseases and Immunology; Sexual Health, St George Hospital, University of New South Wales
Project title: Novel mechanisms of complement control protein dysregulation contributing to age-related macular degeneration pathogenesis and progression: CFH and beta 2-Glycoprotein.
2014 Research Grants Program
In 2014, a single $100,000 grant, paid over two years, was funded by Blackmores Institute, Blackmore Foundation and Macular Disease Foundation Australia as one of the grants under MDFA’s Research Grants Program.
-
Professor Bamini Gopinath
Professor Gopinath was awarded the Blackmores Dr Paul Beaumont Research Fellowship.
Institution: Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney
Project title: Establishing the dietary and lifestyle risk factor profile of a large cohort of clinic patients presenting with late AMD.
2013 Research Grants Program
On World Sight Day in October 2013, MDFA awarded Research Grants, totalling $600,000 over three years, at an event held at the Sydney Opera House.
-
Professor Erica Fletcher
Institution: Department of Anatomy and Neuroscience, University of Melbourne
Project title: Purinergic receptors and early AMD: a novel mechanism and biomarker. -
Professor Damien Harkin
Institution: School of Biomedical Sciences, Queensland University of Technology
Project title: A novel tissue substitute for repairing the outer retina in patients with AMD.
2012 Research Grants Program
As part of the Macular Disease Foundation Australia Research Grants program, in 2012 MDFA awarded the Blackmores Dr Paul Beaumont Research Fellowship. This Fellowship was launched in 2011 in recognition of the Foundation’s Founding Director, Dr Paul Beaumont AO. The Fellowship was supported by MDFA, Blackmores and the Marcus Blackmore Foundation.
-
Professor Bamini Gopinath
Professor Gopinath received the Blackmores Dr Paul Beaumont Research Fellowship.
Institution: Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney
Project title: Targeted Actions to Identify Modifiable Nutritional and Lifestyle Factors for AMD among Persons in the BMES and other Population Studies.
2011 inaugural Research Grants Program
In 2011 the Foundation awarded its inaugural research grants, totalling $694,000 over three years, at an event hosted by Her Excellency Ms Quentin Bryce AC, CVO, the Governor-General of the Commonwealth of Australia.
Additionally, MDFA awarded its inaugural 12-month Blackmores Paul Beaumont Research Fellowship. The Research Fellowship was launched in recognition of MDFA’s Founding Director, Dr Paul Beaumont AO.
The Fellowship was awarded to researchers based in eligible Australian institutions to pursue research into nutritional and/or lifestyle aspects of age-related macular degeneration. Funding was provided by MDFA’s Research Grants Program and Blackmores.
-
Professor Paul Mitchell
Institution: Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney
Project title: Comparison of the risk factor, quality of life and utility value profile of a large age-related macular degeneration patient sample with a population-based cohort.
-
Professor Robyn Guymer
Institution: Centre for Eye Research Australiar
Project title: Improved characterisation of high-risk phenotypes in early age-related macular degeneration, employing novel imaging and functional modalities.
-
Dr Liubov Robman
Dr Robman was awarded the Blackmores Dr Paul Beaumont Research Fellowship.
Institution: Centre for Eye Research Australia
Project title: Dietary patterns and risk of age-related macular degeneration.